Yee, Karen W L <br/><br/>
Emerging drugs for chronic lymphocytic leukaemia.  [electronic resource] 

 -  Expert opinion on emerging drugs  Mar 2006 
 - 167-89 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1744-7623 
<br/><br/><label>Standard No.: </label>10.1517/14728214.11.1.167  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>B7-1 Antigen--immunology<br/>Biphenyl Compounds--pharmacology<br/>Clinical Trials as Topic<br/>Drug Evaluation, Preclinical<br/>HLA-DR Antigens--pharmacology<br/>Humans<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Nitrophenols<br/>Oligonucleotides, Antisense--genetics<br/>Piperazines<br/>Proto-Oncogene Proteins c-bcl-2--antagonists & inhibitors<br/>Sialic Acid Binding Ig-like Lectin 2--immunology<br/>Signal Transduction--drug effects<br/>Sulfonamides<br/>Thionucleotides--genetics